George Freeman MP gives keynote address at Norwich Research Park Microbiome Research to Revenue Leadership Seminar

2 March 2017

The microbiome is a complex community of bacteria, fungi and viruses that is becoming of increasing interest due to new applications in human and animal health, skincare and agronomics.

Norwich Research Park has collaborated with One Nucleus - the international membership organisation for life science and healthcare companies - to deliver a Leadership Seminar focusing on the microbiome and how research in this area is being commercialised.

Microbiome - Research to Revenue held at Centrum on Norwich Research Park was a one day seminar which brought together the innovation supply chain within the microbiome sector. Speakers included major corporates such as Unilever, Nestle and AB Agri plus leading investors Seventure Partners and Arix Bioscience, as well as a range of start-ups who showcased the latest innovative products and services in the sector.

The keynote address was given by George Freeman, MP and Chair of the Prime Minister’s Policy Board. He highlighted Norwich Research Park’s unique community of world class research organisations and growing companies translating innovative ideas into innovative products.

Norwich Research Park is one of Europe’s leading centres for research in Med Biotech, Food & Health, Genomics, Agri Biotech and Industrial Biotech. This event highlights these research strengths.

The Park is home to 3000 researchers/clinicians and creates a supportive environment for around 75 start ups by providing access to research expertise, scientific facilities and business support.

The microbiome has been a hot topic in the news and investment in this research area is growing at a fast rate. The Park will soon be home to the Quadram Institute (QI), which will be housed in a new multi-million-pound centre for food and health research due for completion in 2018.QI will bring together in one building academic researchers, clinicians and patients with a focus on gastroenterology and the gut microbiome, food bio-actives, nutrition and food safety and aims to work with industry to deliver a step change in the treatment and management of diet-related health conditions.

Professor Ian Charles, director, Institute of Food Research (IFR) and QI gave the opening presentation at the Microbiome – Research to Revenue Leadership Seminar. He explained that

“there is an exceptional set of resources and expertise at the Norwich Research Park enabling the new Quadram Institute to be a world-leading research facility across our areas of interest, namely the gut, microbes, food and health.”

Dr Sally Ann Forsyth, chief executive officer, Norwich Research Park said:

“Norwich Research Park was delighted to host the Leadership seminar which brought together key players in microbiome commercialisation and highlighted the fantastic opportunities in this field”.